Jin-Xiong She
Director
Professor
Academic Appointment(s)
Medical College of Georgia
Department of Obstetrics and Gynecology
The Graduate School
College of Allied Health Sciences
Department of Undergraduate Health Professions: Medical Laboratory, Imaging and Radiologic Sciences
Other Duties
Director, Center for Biotechnology and Genomic Medicine
Eminent Scholar Chair in Genomic Medicine, Center for Biotechnology and Genomic Medicine
Eminent Scholar Chair in Genomic Medicine, Center for Biotech and Gen Med
- (706) 721-3410
- (706) 721-3688
- CA II 4126
Education
-
Ph.D., Biochemistry
University of Montpellier, 1987
-
MS, Fishing and Fisheries Sciences
National School of Agriculture, 1984
-
BS, Fishing and Fisheries Sciences
Agric Col of Central China, 1982
Courses Taught Most Recent Academic Year
-
GNMD 9210
Inves of a Prob Genomic Med: Investigation of a Problem
-
GNMD 9300
Research in Genomic Medicine
-
GNMD 8060
Genomic Medicine Seminar
-
GNMD 8052
Func Geno & Prote Using Anml M
-
MDPH 5098
MDPHD Transition Research
Scholarship
Selected Recent Publications
- Factors that Increase Risk of Celiac Disease Autoimmunity Following a Gastrointestinal Infection in Early Life., 2016
Journal Article, Academic Journal
- Reversion of β-Cell Autoimmunity Changes Risk of Type 1 Diabetes: TEDDY Study., 2016
Journal Article, Academic Journal
- Co-targeting EGFR and survivin with a bivalent aptamer-dual siRNA chimera effectively suppresses prostate cancer., 2016
Journal Article, Academic Journal
- Growth and Risk for Islet Autoimmunity and Progression to Type 1 Diabetes in Early Childhood: The Environmental Determinants of Diabetes in the Young Study., 2016
Journal Article, Academic Journal
- Complement gene variants in relation to autoantibodies to beta cell specific antigens and type 1 diabetes in the TEDDY Study., 2016
Journal Article, Academic Journal
Research Interests
Dr. She's research focuses on the development and application of high throughput technologies (Genomics, Transcriptomics, Proteomics, Glycomics, Bioinformatics, Drug Screening and Drug Design) for biomarker discovery and novel intervention strategies for autoimmune diseases, diabetic complications and various types of cancer.
